No Data
No Data
Wolf Haldenstein Adler Freeman & Herz LLP Announces That It Is Investigating Atara Biotherapeutics, Inc. for Potential Violations of Securities Laws
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Express News | Atara Biotherapeutics Inc - to Reduce Workforce by 50%
H.C. Wainwright Maintains Atara Biotherapeutics(ATRA.US) With Hold Rating
Atara Biotherapeutics Faces Uncertainty Amid FDA Clinical Hold and Financing Needs, Resulting in Hold Rating
kingrotch : thank you for your work![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
![pray 🙏](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f64f-1f3fb.png)
真名有晨 : Thank you very much
Please take care and rest.
iluvpoptarts : sry doc. I'm too busy counting the money your making me too look. muha
IamBadNewz : @Jaguar8 Been waiting (im)patiently for a pop on CGTX given the recent conference and news of insider buying but price hasn’t reacted. Your thoughts?
Jaguar8 OP IamBadNewz : You have to be patient
View more comments...